vTv Therapeutics

Focused on treating metabolic diseases

vTv is focused on developing oral small molecule drug candidates. The company has a pipeline of clinical drug candidates led by programs for the treatment of type 1 diabetes, Alzheimer’s disease, and inflammatory disorders. vTv’s development partners are pursuing additional indications in type 2 diabetes, chronic obstructive pulmonary disease (COPD), and genetic mitochondrial diseases.

Status
NASDAQ: VTVT
Year of Investment
2020
Strategy
Life Sciences
Location
High Point, North Carolina